AnalystsJason N. ButlerJason N. Butler's Stock Forecasts
AnalystsJason N. Butler
Sectors:
Industries:
Analyst Ranking
Top 40%
#2037 out of 5087 analysts
Average Return
+9.09%
Win Rate
63%5 out of 8
Risk vs Reward
Poor
Good
Jason N. Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Precigen IncPGEN | +28.57% | $3.22 | $4.14 | 2025-08-19 - 2025-10-31 | Buy |
Cytokinetics IncCYTK | +28.15% | $49.62 | $63.59 | 2025-09-02 - 2025-10-31 | Buy |
Abivax SaABVX | +24.90% | $82.00 | $102.42 | 2025-09-25 - 2025-10-31 | Buy |
Zevra Therapeutics IncZVRA | +7.95% | $9.43 | $10.18 | 2025-08-13 - 2025-10-31 | Buy |
Terawulf IncWULF | +6.90% | $14.50 | $15.50 | 2025-10-29 - 2025-10-31 | Buy |
Jason N. Butler Analyst Color
Get additional color on Jason N. Butler's coverage of popular stocks
Jason N. Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Terawulf IncWULF | 1 | Buy | $22.00 | +41.94% | Maintains | 5 days ago |
Rezolute IncRZLT | 1 | Buy | $17.00 | +82.40% | Maintains | 5 days ago |
Abivax SaABVX | 1 | Buy | $114.00 | +11.31% | Maintains | a month ago |
Cormedix IncCRMD | 1 | Buy | $22.00 | +97.66% | Reiterates | 2 months ago |
Cytokinetics IncCYTK | 1 | Buy | $78.00 | +22.66% | Reiterates | 2 months ago |
Precigen IncPGEN | 1 | Buy | $8.00 | +93.24% | Maintains | 2 months ago |
Zevra Therapeutics IncZVRA | 1 | Buy | $18.00 | +76.82% | Maintains | 3 months ago |
Acadia Pharmaceuticals IncACAD | 1 | Buy | $35.00 | +54.19% | Maintains | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.